References
- Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601–11
- Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010;31:702–55
- Kaprara A, Krassas GE. Thyroid autoimmunity and miscarriage. Hormones (Athens) 2008;7:294–302
- van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011;17:605–19
- Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011;342:d2616
- Rushworth FH, Backos M, Rai R, et al. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 2000;15:1637–9
- Yan J, Sripada S, Saravelos SH, et al. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril 2012;98:378–82
- Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod 2015;30:495–8
- Goddijn M, van den Boogaard E, Steepers EA, et al. The guideline ‘Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology. Ned Tijdschr Geneeskd 2008;152:1665–70
- Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006;21:2216–22
- Franssen MT, Korevaar JC, van der Veen F, et al. Management of recurrent miscarriage: evaluating the impact of a guideline. Hum Reprod 2007;22:1298–303
- Vissenberg R, van den Boogaard E, van WM, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update 2012;18:360–73